You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model

Article metrics

Article menu

This article has a correction. Please see:

XML
Basic tumor immunology
Original research
Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model

 

Online download statistics by month:

Online download statistics by month: February 2021 to July 2025

AbstractFullPdf
Feb 202130030081
Mar 202131531555
Apr 202110910928
May 202110710724
Jun 202110310323
Jul 2021818112
Aug 202110810821
Sep 2021959530
Oct 202111511540
Nov 2021878730
Dec 2021808016
Jan 2022626315
Feb 202242439
Mar 2022747725
Apr 2022555724
May 2022485026
Jun 2022626221
Jul 2022525325
Aug 2022606122
Sep 2022868635
Oct 2022636827
Nov 2022495121
Dec 2022313214
Jan 2023414331
Feb 2023707025
Mar 2023333624
Apr 2023242414
May 2023434322
Jun 2023363614
Jul 2023222217
Aug 2023252518
Sep 2023212114
Oct 202334348
Nov 202355557
Dec 202318818817
Jan 2024363715
Feb 2024545420
Mar 2024363640
Apr 2024676822
May 2024404020
Jun 2024343519
Jul 2024707128
Aug 2024282712
Sep 20244750506
Oct 2024383930
Nov 2024596153
Dec 2024707120
Jan 2025393920
Feb 202511411413
Mar 2025636329
Apr 2025797937
May 2025535533
Jun 2025282820
Jul 2025110
Total373237681772